Ginkgo Bioworks Holdings (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,535 | 143,864 | 167,202 | 111,065 | 203,566 |
| Marketable Securities | 217,628 | 229,592 | 255,418 | 350,797 | 270,125 |
| Receivables | 13,013 | 20,269 | 24,255 | 22,359 | 23,126 |
| TOTAL | $332,535 | $409,955 | $471,838 | $506,082 | $523,025 |
| Non-Current Assets | |||||
| PPE Net | 157,185 | 163,020 | 167,371 | 176,579 | 186,354 |
| Investments And Advances | 22,390 | 14,703 | 15,066 | 30,175 | 32,662 |
| Intangibles | 44,387 | 48,860 | 53,482 | 61,522 | 66,152 |
| Other Non-Current Assets | 433,549 | 396,537 | 411,939 | 414,807 | 422,816 |
| TOTAL | $657,511 | $623,120 | $647,858 | $683,083 | $707,984 |
| Total Assets | $990,046 | $1,033,075 | $1,119,696 | $1,189,165 | $1,231,009 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,575 | 16,309 | 10,566 | 10,704 | 11,202 |
| Accrued Expenses | 49,951 | 48,376 | 66,458 | 79,341 | 57,231 |
| TOTAL | $72,740 | $79,595 | $95,970 | $115,281 | $96,720 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,214 | 14,910 | 18,946 | 25,236 | 28,287 |
| Other Non-Current Liabilities | 420,485 | 432,432 | 439,954 | 440,029 | 446,771 |
| TOTAL | $497,022 | $510,327 | $515,136 | $514,101 | $521,337 |
| Total Liabilities | $569,762 | $589,922 | $611,106 | $629,382 | $618,057 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,340 | 65,324 | 61,924 | 60,590 | 59,200 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -6,279,617 | -6,232,907 | -6,150,320 | -6,069,569 | -5,988,814 |
| Other shareholders' equity | 950 | 1,194 | 1,851 | 1,996 | 1,653 |
| TOTAL | $420,284 | $443,153 | $508,590 | $559,783 | $612,952 |
| Total Liabilities And Equity | $990,046 | $1,033,075 | $1,119,696 | $1,189,165 | $1,231,009 |